Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry.

Kuklenyik Z, Jones JI, Gardner MS, Schieltz DM, Parks BA, Toth CA, Rees JC, Andrews ML, Carter K, Lehtikoski AK, McWilliams LG, Williamson YM, Bierbaum KP, Pirkle JL, Barr JR.

PLoS One. 2018 Apr 10;13(4):e0194797. doi: 10.1371/journal.pone.0194797. eCollection 2018.

2.

High throughput quantification of apolipoproteins A-I and B-100 by isotope dilution MS targeting fast trypsin releasable peptides without reduction and alkylation.

Parks BA, Schieltz DM, Andrews ML, Gardner MS, Rees JC, Toth CA, Jones JI, McWilliams LG, Kuklenyik Z, Pirkle JL, Barr JR.

Proteomics Clin Appl. 2017 Jul;11(7-8). doi: 10.1002/prca.201600128. Epub 2017 Apr 3.

3.

Detection of methicillin-resistant Staphylococcus aureus using phage amplification combined with matrix-assisted laser desorption/ionization mass spectrometry.

Rees JC, Barr JR.

Anal Bioanal Chem. 2017 Feb;409(5):1379-1386. doi: 10.1007/s00216-016-0070-3. Epub 2016 Nov 19.

4.

On-column trypsin digestion coupled with LC-MS/MS for quantification of apolipoproteins.

Toth CA, Kuklenyik Z, Jones JI, Parks BA, Gardner MS, Schieltz DM, Rees JC, Andrews ML, McWilliams LG, Pirkle JL, Barr JR.

J Proteomics. 2017 Jan 6;150:258-267. doi: 10.1016/j.jprot.2016.09.011. Epub 2016 Sep 23.

PMID:
27667389
5.

A Proteomic Characterization of Bordetella pertussis Clinical Isolates Associated with a California State Pertussis Outbreak.

Williamson YM, Moura H, Whitmon J, Woolfitt AR, Schieltz DM, Rees JC, Guo S, Kirkham H, Bouck D, Ades EW, Tondella ML, Carlone GM, Sampson JS, Barr JR.

Int J Proteomics. 2015;2015:536537. doi: 10.1155/2015/536537. Epub 2015 May 24.

6.

Simultaneous Identification and Susceptibility Determination to Multiple Antibiotics of Staphylococcus aureus by Bacteriophage Amplification Detection Combined with Mass Spectrometry.

Rees JC, Pierce CL, Schieltz DM, Barr JR.

Anal Chem. 2015 Jul 7;87(13):6769-77. doi: 10.1021/acs.analchem.5b00959. Epub 2015 Jun 8.

7.

Obsessive-compulsive disorder and gut microbiota dysregulation.

Rees JC.

Med Hypotheses. 2014 Feb;82(2):163-6. doi: 10.1016/j.mehy.2013.11.026. Epub 2013 Dec 1.

PMID:
24332563
8.

Modified MALDI MS fatty acid profiling for bacterial identification.

Voorhees KJ, Jensen KR, McAlpin CR, Rees JC, Cody R, Ubukata M, Cox CR.

J Mass Spectrom. 2013 Jul;48(7):850-5. doi: 10.1002/jms.3215.

PMID:
23832941
9.

Modeling bacteriophage amplification as a predictive tool for optimized MALDI-TOF MS-based bacterial detection.

Cox CR, Rees JC, Voorhees KJ.

J Mass Spectrom. 2012 Nov;47(11):1435-41. doi: 10.1002/jms.3087.

PMID:
23147819
10.

Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification.

Wang D, Baudys J, Ye Y, Rees JC, Barr JR, Pirkle JL, Kalb SR.

Anal Biochem. 2013 Jan 15;432(2):115-23. doi: 10.1016/j.ab.2012.09.021. Epub 2012 Sep 24.

11.

De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics.

Kalb SR, Baudys J, Rees JC, Smith TJ, Smith LA, Helma CH, Hill K, Kull S, Kirchner S, Dorner MB, Dorner BG, Pirkle JL, Barr JR.

Anal Bioanal Chem. 2012 Apr;403(1):215-26. doi: 10.1007/s00216-012-5767-3. Epub 2012 Mar 7.

12.

Viable Staphylococcus aureus quantitation using ¹⁵N metabolically labeled bacteriophage amplification coupled with a multiple reaction monitoring proteomic workflow.

Pierce CL, Rees JC, Fernández FM, Barr JR.

Mol Cell Proteomics. 2012 Jan;11(1):M111.012849. doi: 10.1074/mcp.M111.012849. Epub 2011 Oct 4.

13.

Detection of Staphylococcus aureus using 15N-labeled bacteriophage amplification coupled with matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry.

Pierce CL, Rees JC, Fernández FM, Barr JR.

Anal Chem. 2011 Mar 15;83(6):2286-93. doi: 10.1021/ac103024m. Epub 2011 Feb 22.

PMID:
21341703
15.

Body weight change and mortality in a cohort of elderly patients recently discharged from the hospital.

Sullivan DH, Liu L, Roberson PK, Bopp MM, Rees JC.

J Am Geriatr Soc. 2004 Oct;52(10):1696-701.

PMID:
15450047
16.
17.
18.

Mediterranean spotted fever mimicking Kawasaki disease.

Jenkins DR, Rees JC, Pollitt C, Cant A, Craft AW.

BMJ. 1997 Mar 1;314(7081):655-6. No abstract available.

19.

Collection of urine from washed-up potties.

Rees JC, Vernon S, Pedler SJ, Coulthard MG.

Lancet. 1996 Jul 20;348(9021):197. No abstract available.

PMID:
8684173
20.

Childhood neoplasia and Haemophilus influenzae type b vaccine failure.

Jenkins DR, Rees JC, Hale JP, Pedler SJ.

Lancet. 1996 Jul 13;348(9020):131. No abstract available.

PMID:
8676697
21.

Holy water--a risk factor for hospital-acquired infection.

Rees JC, Allen KD.

J Hosp Infect. 1996 Jan;32(1):51-5.

PMID:
8904372
22.
23.
24.

Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase-elevating virus-associated changes.

Stevenson MM, Rees JC, Meltzer MS.

J Immunol. 1980 Jun;124(6):2892-9. No abstract available.

PMID:
7373055
25.

Mediation of macrophage collagenase production by 3'-5' cyclic adenosine monophosphate.

McCarthy JB, Wahl SM, Rees JC, Olsen CE, Sandberg L, Wahl LM.

J Immunol. 1980 May;124(5):2405-9.

PMID:
6245142
26.

Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice.

Pennline KJ, Evans SB, Nawrocki JF, Rees JC, Johnson CS, Vallera DA, Dodd MC.

Br J Cancer. 1979 Mar;39(3):247-58.

27.

Cellular immunity in neoplasia. Antigen and mitogen responses in patients with bronchiogenic carcinoma.

Rees JC, Rossio JL, Wilson HE, Minton JP, Dodd MC.

Cancer. 1975 Dec;36(6):2010-5.

PMID:
173458

Supplemental Content

Support Center